Haemonetics (HAE)
(Delayed Data from NYSE)
$75.08 USD
-0.41 (-0.54%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $75.08 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 1.09 |
EPS Last Quarter | 1.02 |
Last EPS Surprise | -0.97% |
ABR | 1.78 |
Earnings ESP
|
-0.62% |
---|---|
Current Year | 4.57 |
Next Year | 5.24 |
EPS (TTM) | 3.95 |
P/E (F1) | 16.51 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 343.02M | 358.81M | 1.39B | 1.44B |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 347.83M | 359.80M | 1.40B | 1.46B |
Low Estimate | 340.50M | 357.99M | 1.39B | 1.43B |
Year ago Sales | 318.18M | 336.25M | 1.31B | 1.39B |
Year over Year Growth Est. | 7.81% | 6.71% | 6.39% | 3.49% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.09 | 1.23 | 4.57 | 5.24 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | 1.10 | 1.22 | 4.56 | 5.11 |
High Estimate | 1.10 | 1.28 | 4.60 | 5.43 |
Low Estimate | 1.07 | 1.21 | 4.54 | 5.11 |
Year ago EPS | 0.99 | 1.04 | 3.96 | 4.57 |
Year over Year Growth Est. | 10.10% | 18.27% | 15.40% | 14.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 2 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 1.09 | 1.23 | 4.57 | 5.24 |
7 Days Ago | 1.09 | 1.23 | 4.57 | 5.24 |
30 Days Ago | 1.10 | 1.23 | 4.58 | 5.14 |
60 Days Ago | 1.11 | 1.22 | 4.57 | 5.12 |
90 Days Ago | 1.11 | 1.22 | 4.57 | 5.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.08 | 1.22 | 4.55 | 5.27 |
Zacks Consensus Estimate | 1.09 | 1.23 | 4.57 | 5.24 |
Earnings ESP | -0.62% | -1.01% | -0.41% | 0.56% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.02 | 0.90 | 1.04 | 0.99 | NA |
Estimate | 1.03 | 0.88 | 0.97 | 0.94 | NA |
Difference | -0.01 | 0.02 | 0.07 | 0.05 | 0.03 |
Surprise | -0.97% | 2.27% | 7.22% | 5.32% | 3.46% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more